Location permission needed for a better experience.
How can we help you?
EN
Hızlı Randevu
Hastane
Randevusu
Görüntülü Görüşme Randevusu
Education
  • 2017 Mustafa Kemal University Tayfur Ata Sökmen Faculty of Medicine Endokrinoloji ve Metabolizma Hastalıkları
  • 2011 Ankara Numune Eğitim ve Araştırma Hospital İç Hastalıkları
  • 2004 Hacettepe University Faculty of Medicine
Experience
  • 2024 Acıbadem Healthcare Services
  • 2019 - 2024 Ordu Medical Park Hospital
  • 2017 - 2019 Kastamonu Devlet Hospital -Endokrinoloji ve Metabolizma Hastalıkları Uzmanlığı
  • 2011 - 2017 Mustafa Kemal University -Endokrinoloji ve Metabolizma Hastalıkları Bilim Dalı
  • 2011 Yozgat Boğazlıyan Devlet Hospital- İç Hastalıkları Uzmanlığı Mecburi Hizmeti
PUBLICATIONS
  • Relation of red celi distribution width with dipper and non-dipper hypertension Med Glas (Zenica). 2016 Aug 1 ;13(2):75-81. doi: 10.17392/859-16. PubMed PMID: 27452327. Buyukkaya E, Erayman A, Karakas E, Buğra NacarA, Kurt M, Buyukkaya S, Burak Akcay A, Sen N.
  • Evaluation of the effects of red blood celi distribution width on survival in lung cancer patients Contemp Oncol (Pozn). 2016;20(2):153-7. doi: 10.5114/wo.2016.60072. Epub 2016 Jun 14. PubMed PMID: 27358595; PubMed Central PMCID: PMC4925737. Kos M, Hocazade C, Kos FT, Uncu D, Karakas E, Doğan M, Uncu HG, Ozdemir N, Zengin N.
  • Prognostic role of pretreatment platelet/lymphocyte ratio in patients with non-small celi lung cancer. Wien Klin VVochenschr. 2016 Sep;128(17-18):635-40. doi: 10.1007/S00508-015-0724-8. Epub 2015 Feb 27. PubMed PMID: 25720573. Kos M, Hocazade C, Kos FT, Uncu D, Karakas E, Doğan M, Uncu HG, Yildirim N, Zengin N.
  • Assessment of Prognostic Value of "Neutrophil to Lymphocyte Ratio" and "Prognostic Nutritional lndex" as a Sytemic Inflammatory Marker in Non-small Celi Lung Cancer Asian Pac J Cancer Prev. 2015;16(9):3997-4002. PubMed PMID: 25987075. Kos FT, Hocazade C, Kos M, Uncu D, Karakas E, Doğan M, Uncu HG, Ozdemir N, Zengin N.
  • Left ventricular dyssynchrony is an early manifestation of heart involvement in sickle celi anemia Echocardiography. 2013 May;30(5):521-6. doi: 10.1111/echo.12085. Epub2013 Jan 11. PubMed PMID: 23305504. Karakaş MF, Büyükkaya E, Kurt M, Çelik M, Karakaş E, Büyükkaya S, Akçay AB, Sen N.
.
.
.

Contact Us

Fill out the form below for your information requests

As Acıbadem Healthcare Group, you can report your requests, suggestions, thanks and complaints by filling out the form below or by contacting us at +90 538 685 39 52 so that we can provide you with a better and higher quality service.

See More
See More
Security Code

INFORMATION NOTICE ON THE PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. and its controlling and affiliated companies listed in Annex-1 (each referred to individually as the "Company" and collectively as the "Companies") process your general and/or special category personal data (including but not limited to health data) ("Personal Data") in the capacity of Data Controller under the Personal Data Protection Law No. 6698 ("Law") and related legislation. Processing of Personal Data is carried out in accordance with the framework outlined below and in compliance with the Fundamental Law on Health Services No. 3359, the Decree Law No. 663 on the Organization and Duties of the Ministry of Health and its Affiliated Institutions, the Regulation on the Provision of Remote Health Services, the Private Hospitals Regulation, the Ministry of Health regulations, and other relevant legislation.

I. Acquisition, Processing, and Purposes of Processing Personal Data

Your Personal Data is obtained through verbal, written, visual, or electronic channels (such as our website, mobile applications, and call center) for the purposes of protecting public health, preventive medicine, medical diagnosis, treatment and care services, and the planning and management of healthcare services and their financing, in alignment with the Company's fields of activity. The Personal Data processed by the Company, including but not limited to the following, is collected and processed proportionally and in connection with these purposes:

Your Personal Data may be processed under the conditions specified in Articles 5 and 6 of the Law for the following purposes:

II. Transfer of Personal Data

Your Personal Data may be shared with:

III. Method and Legal Basis for Collecting Personal Data

Your Personal Data is collected through verbal, written, visual, or electronic means for the lawful execution of the Company's activities and compliance with contractual and legal obligations. The legal basis for collection includes:

As per Article 6 - (3) of the Law, personal data related to health and sexual life may be processed without explicit consent by persons or institutions subject to confidentiality obligations for public health protection, preventive medicine, medical diagnosis, treatment, and care services, as well as the planning and management of healthcare financing.

IV. Your Rights Regarding the Protection of Personal Data

Under Article 11 of the Law, you have the right to:

V. Data Security

The Companies ensure the security of Personal Data by implementing necessary technical and administrative measures in accordance with information security standards and procedures.

VI. Complaints and Contact Information

To exercise your rights under the Law, you may submit a request through the methods specified in the "Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. Data Subject Application Form" available at https://www.acibadem.com.tr/acibademonline/images/Ac%C4%B1badem_Veri_Sahibi_Basvuru_Formu.pdf.

Requests can be submitted by mail, notarized document, or secure electronic means to:

ANNEX-1: List of Companies

 

TOP x""